SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$FUUU is a Solana-based memecoin that was launched on http://Pump.fun in March 2024. The project is themed around the Rage Guy character, a figure that originated in the rage comic era of the late 2000s and became widely recognized across internet culture. Following the launch, the original developer discontinued involvement with the token. At that point, the CTO team assumed responsibility for coordinating ongoing community efforts around the project.  The stated purpose of $FUUU is cultural rather than financial. It is designed as a “culture coin” that highlights Rage Guy as a symbolic and relatable figure. The character’s expression of frustration, commonly represented by the text “FFFFUUUU,” reflects emotions that are often tied to both cryptocurrency markets and everyday experiences. By building a token around this meme, the project aims to preserve a recognizable piece of internet history within a blockchain context.  Unlike projects that emphasize detailed roadmaps, technical milestones, or defined utility, $FUUU positions itself as a lighthearted and entertainment-driven token. There are no team allocations, no taxes, and no embedded promises of profit or financial return. The coin is intended solely for cultural engagement, community participation, and meme creation. Holders and community members are encouraged to contribute through content, discussion, and the continued use of Rage Guy imagery, but there are no obligations or formal expectations tied to the token.  The CTO team provides organizational support, and back end support such as hiring an artist and creatin websites, the community drives activity associated with the project. This includes creating and sharing memes, maintaining discussion channels, and ensuring the Rage Guy character remains present in contemporary internet culture. The project does not claim utility beyond its role as a culture coin, and its sustainability depends entirely on voluntary participation and ongoing community interest.  From a transparency standpoint, the on-chain parameters of the token are publicly visible. These include the mint authority status, freeze authority, liquidity details (whether burned or locked), and circulating supply information. Any locked or burn addresses are disclosed for the purpose of supporting accurate supply tracking on external platforms.  Rage Guy ($FUUU) should not be viewed as an investment. The token has no intrinsic value and provides no rights, revenue, or guarantees to holders. As with all cryptoassets, trading is highly risky, and participants are advised to conduct their own research and fully understand the risks involved. The project’s focus remains cultural preservation and community expression rather than financial

FUUUUUUUUUUUUUU

FUUU is trending as a highly speculative meme coin that has captured investor attention through rapid price action and community-driven momentum. Participants are actively debating whether the token serves as a legitimate trading opportunity or a high-risk pump-and-dump scheme.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is facing significant volatility following a weak profit outlook that overshadowed its recent earnings beat, prompting debates among investors about whether the stock is a long-term bargain or currently overvalued. The broader cybersecurity sector remains under pressure as market participants weigh fears that AI-driven tools could disrupt established security stacks against the industry's fundamental demand for robust, enterprise-grade protection.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending as investors react to strategic financing news intended to extend the company's operational runway into 2026, alongside discussions regarding the anticipated March 2026 phase 3 trial data for myelofibrosis. The community remains deeply polarized, with many retail investors expressing frustration over past share dilution and leadership performance, while others are closely monitoring high-stakes trial outcomes as a potential catalyst for a significant valuation rerating.

Satellogic, Inc. operates as a vertically integrated geospatial company. It is creating and continuously enhancing the first scalable, fully automated EO platform with the ability to remap the entire planet at both high-frequency and high-resolution, providing accessible and affordable solutions for customers. The company was founded by Emiliano Kargieman and Gerardo Richarte in July 2010 and is headquartered in Davidson, NC.

Satellogic Inc - Ordinary Shares - Class A

Satellogic is gaining significant community attention as investors rally around the company's expanding partnership with the U.S. Office of Naval Research and upcoming launch campaigns. Traders are closely monitoring key technical support levels while speculating that the company's participation in major defense and space industry events could catalyze further momentum.

Tidal Trust II - YieldMax XYZ Option Income Strategy ETF

YieldMax XYZ Option Income Strategy ETF

YieldMax XYZ Option Income Strategy ETF is currently trending as investors discuss ongoing reverse splits across several YieldMax funds and the impact of the underlying asset's recent integration of new stablecoin and Bitcoin payment features. The community is actively debating the trade-offs between high-yield income generation and NAV erosion, with many traders sharing tactical strategies for redeploying cash distributions to manage underwater positions.

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication; Energy, Utilities, Resources, and Services; Manufacturing, Hi-Tech, Life Sciences, and All Other. The company was founded by Dinesh Krishnan Swamy, Senapathy Gopalakrishnan, Narayana Ramarao Nagavara Murthy, Raghavan N. S., Ashok Arora, Nandan M. Nilekani, and S. D. Shibulal on July 2, 1981 and is headquartered in Bangalore, India.

Infosys Ltd - ADR

Infosys Technologies Limited

Infosys is trending as investors debate the impact of AI on its traditional IT services model, with active community discussions centering on the company's recent AI partnerships and potential headwinds from labor policy shifts.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is currently a focal point for investors navigating the AI marketing sector, as the community actively debates whether the stock's recent volatility is a temporary dip or a sign of deeper underlying pressure. While many participants express frustration over price movement following recent earnings and product launches, a significant portion of the community remains bullish, citing a strong data moat and long-term potential as they use pullbacks as a buying opportunity.

Devon Energy Corp. engages in the exploration, development, and production of oil and natural gas properties. It develops and operates Delaware Basin, Eagle Ford, Heavy Oil, Barnett Shale, STACK, and Rockies Oil. The company was founded by J. Larry Nichols and John W. Nichols in 1971 and is headquartered in Oklahoma City, OK.

Devon Energy Corp.

Devon Energy is trending due to reports of advanced merger discussions with Coterra Energy, a move investors are monitoring closely for potential synergy-driven value creation in the Delaware Basin. The community is actively debating the strategic merits of this potential shale tie-up, with many participants analyzing how such a consolidation might impact future dividends, production scale, and shareholder returns in a volatile commodity environment.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is seeing significant market activity as investors weigh a wave of regulatory progress, including Department of Energy approvals and NRC license wins, against the backdrop of its pre-revenue status and an upcoming earnings report. The community remains sharply divided, with bulls pointing to the company's long-term energy security potential for AI infrastructure, while bears express skepticism over heavy cash burn, insider selling, and the distance between current valuations and operational reality.

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corp. - Ordinary Shares (Paired Stock)

Carnival Corp

Carnival Corp is facing significant downward pressure as investors react to rising oil prices and geopolitical instability, despite strong underlying bookings and recent positive analyst sentiment. The community is sharply divided, with many long-term holders viewing the pullback as a buying opportunity while others express frustration over the stock's volatility and its susceptibility to broader market fears.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) COO Sells 3,116 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) COO Nathan Dowden sold 3,116 shares of the firm's stock in a transaction that occurred on Monday, March 9th. The stock was sold at an...

Entrada Therapeutics (NASDAQ:TRDA) CFO Kory James Wentworth Sells 5,089 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 5,089 shares of the firm's stock in a transaction that occurred on Monday, March 9th. The shares were sold at...

Entrada Therapeutics (NASDAQ:TRDA) COO Sells $155,216.70 in Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) COO Nathan Dowden sold 11,894 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $13.05...

Entrada Therapeutics (NASDAQ:TRDA) CFO Kory James Wentworth Sells 11,388 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 11,388 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was sold at an average...

Entrada Therapeutics (NASDAQ:TRDA) Hits New 1-Year High - Time to Buy?

Entrada Therapeutics (NASDAQ:TRDA) Reaches New 12-Month High - Still a Buy...

Entrada Therapeutics (NASDAQ:TRDA) CFO Kory James Wentworth Sells 7,988 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 7,988 shares of the business's stock in a transaction on Wednesday, March 4th. The stock was sold at an...

Kory James Wentworth Sells 7,988 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 7,988 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an...

Royce & Associates LP Raises Stock Position in Entrada Therapeutics, Inc. $TRDA

Royce & Associates LP grew its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA - Free Report) by 54.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Entrada Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS

Entrada Therapeutics (NASDAQ:TRDA - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.94) earnings per share (EPS) for the quarter, topping the consensus...

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The company’s oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Entrada Therapeutics Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

TRDA
Entrada Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TRDA News

TRDAEntrada Therapeutics Inc